BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Irvine Pharmaceutical Services, Inc. Announces Aggressive Growth Strategies, Initiatives


3/5/2013 12:40:57 PM

IRVINE, CA — Irvine Pharmaceutical Services announced today its 2013 strategic plan for dramatically increased capacity over the course of this fiscal year.

The company’s move to incorporate its Avrio parenteral manufacturing facility into the Irvine brand in January was the first step in what Dr. Assad J. Kazeminy, CEO and founder, described as a three-prong initiative for aggressive yet stable growth: more highly trained technical personnel, state-of-the-art instrumentation and increased capacity for formulation, biopharmaceuticals and raw material testing.

We have been building to this trajectory for the past five years,” Kazeminy said. “We are ‘just in time’ to meet the quickly expanding needs of the biopharmaceutical industry as it adjusts to an improving economy, mounting regulatory restrictions and faster-to-market demands.”

Since the first of the year, Irvine has increased technical staff across most departments and is budgeted to add an additional 40 over the next 12 months.

The plan, as outlined by Kazeminy “is to double our capacity for our filling (both lyophilized and liquid) formulation, and biopharmaceutical development before second quarter 2014. We are committed to our clients and relish the challenge and opportunity.”

About Irvine

Irvine Pharmaceutical Service Inc. is a premier contract development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Irvine proves full cGMP specialized product development services such as preformulation/formulation, analytical development, parenteral manufacturing, stability storage and complete analytical CMC testing. Learn more at www.irvinepharma.com or call 877-445-6554.

Irvine Pharmaceutical Services

10 Vanderbilt

Irvine, California 92618

T: (877) 445-6554

F: (949) 951-4909



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES